Fauci: US may not even need AstraZeneca COVID-19 vaccine



[ad_1]

The United States may not need AstraZeneca’s coronavirus vaccine – even though the vaccine is approved by federal regulators, Dr Anthony Fauci said Thursday.

In an interview with Reuters, Fauci, the White House’s chief medical adviser, said the country already has enough contracts with other vaccine makers to vaccinate the entire population.

“My general feeling is that given the contractual relationships we have with a number of companies, we have enough vaccines to meet all of our needs without having to resort to AstraZeneca,” he said.

WHAT WE KNOW ABOUT ASTRAZENECA VACCINE BLOOD SEAL REPORTS

The nation’s top infectious disease expert added that the United States may have enough vaccines for booster shots in the fall.

“If you look at the numbers (of doses) we’re going to get … it’s likely that we can handle any boost we need, but I can’t say for sure,” he said. to Reuters.

Once hailed as a breakthrough in the fight against COVID-19, AstraZeneca’s shooting has been under surveillance since late last year.

Dr.Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases and Chief Medical Advisor to the President, addresses a group of interfaith clergy and community leaders and leaders at the Washington National Cathedral, for encourage religious communities to obtain the COVID vaccine, Tuesday, March 16, 2021 in Washington.  (AP Photo / Manuel Balce Ceneta)

Dr.Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases and Chief Medical Advisor to the President, addresses a group of interfaith clergy and community leaders and leaders at the Washington National Cathedral, for encourage religious communities to obtain the COVID vaccine, Tuesday, March 16, 2021 in Washington. (AP Photo / Manuel Balce Ceneta)

Last month, more than a dozen countries that had approved the London-based pharmaceutical company’s vax temporarily suspended its use after reports linked it to a rare blood clotting disorder.

Meanwhile, US regulators accused the company of “picking data” to make the shot appear more effective.

Following public criticism, AstraZeneca said the data was based on a “pre-specified interim analysis” and agreed to release an updated report.

The company then released revised results showing decreased, although still strong, efficacy for its inoculation.

CLICK HERE TO GET THE FOX NEWS APP

AstaZeneca also said it plans to seek emergency use clearance from the FDA for the vaccine in a few weeks.

[ad_2]

Source link